Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Validated and Characterized Antibodies

NCI makes validated antibodies and SOPs for biomarker assays available to investigators for their cancer research.

Antibody Characterization Program

NCI's Antibody Characterization Program comprehensively characterizes monoclonal antibodies or other renewable affinity reagents for use in cancer-related research. It operates via its Antibody Characterization Laboratory, which is located at the Frederick National Laboratory for Cancer Research.

Clinical Pharmacodynamic Biomarker Assays

The Division of Cancer Treatment and Diagnosis (DCTD) Clinical Pharmacodynamic Program has developed pharmacodynamic biomarker assays that are intended to be used to investigate drug and downstream drug-induced effects.

  • Reviewed:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Validated and Characterized Antibodies was originally published by the National Cancer Institute.”

Email